Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:BSTG NASDAQ:CODX NASDAQ:DRIO NASDAQ:OBLN NASDAQ:TMDI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBSTGBiostage$4.45$4.45$4.45▼$4.45$61.78M-1.021,847 shsN/ACODXCo-Diagnostics$0.25-0.8%$0.29$0.23▼$2.23$8.46M0.6305,546 shs470,082 shsDRIODarioHealth$0.72+0.2%$0.70$0.50▼$1.55$31.90M1.55286,295 shs150,756 shsOBLNObalon Therapeutics$2.38-2.5%$4.22$0.66▼$10.77$23.85M-1.237.68 million shs126,096 shsTMDITitan Medical$0.14-26.3%$0.23$0.13▼$1.20$15.67M2.364.83 million shs7.71 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBSTGBiostage0.00%0.00%0.00%0.00%0.00%CODXCo-Diagnostics-0.75%-12.89%-15.25%-32.25%-81.75%DRIODarioHealth+0.22%+2.42%-0.14%-0.91%-44.69%OBLNObalon Therapeutics-2.40%+2.95%-0.81%+330.64%+1,020.81%TMDITitan Medical0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBSTGBiostageN/AN/AN/AN/AN/AN/AN/AN/ACODXCo-Diagnostics4.2455 of 5 stars3.53.00.04.42.70.01.3DRIODarioHealth1.9365 of 5 stars3.30.00.00.02.90.81.3OBLNObalon TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ATMDITitan MedicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBSTGBiostage 0.00N/AN/AN/ACODXCo-Diagnostics 3.00Buy$5.502,100.00% UpsideDRIODarioHealth 2.67Moderate Buy$2.00178.16% UpsideOBLNObalon Therapeutics 0.00N/AN/AN/ATMDITitan Medical 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CODX, DRIO, BSTG, TMDI, and OBLN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2025DRIODarioHealthLitchfield Hills ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$3.004/28/2025CODXCo-DiagnosticsD Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/28/2025CODXCo-DiagnosticsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$10.00(Data available from 7/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBSTGBiostageN/AN/AN/AN/A($0.26) per shareN/ACODXCo-Diagnostics$3.91M2.15N/AN/A$1.70 per share0.15DRIODarioHealth$27.04M1.18N/AN/A$2.11 per share0.34OBLNObalon Therapeutics$1.59M15.00N/AN/A$0.60 per share3.97TMDITitan Medical$20.09M0.78N/AN/A$0.32 per share0.44Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBSTGBiostage-$6.07M-$0.58N/A∞N/AN/AN/A-174.43%N/ACODXCo-Diagnostics-$37.64M-$1.17N/AN/AN/A-1,025.45%-60.16%-52.69%8/6/2025 (Estimated)DRIODarioHealth-$42.75M-$0.56N/AN/AN/A-159.80%-65.81%-38.41%8/6/2025 (Estimated)OBLNObalon Therapeutics-$12.33MN/AN/A∞N/A-776.76%-161.38%-83.58%N/ATMDITitan Medical-$14.86M-$0.19N/A∞N/AN/A-167.03%-112.15%N/ALatest CODX, DRIO, BSTG, TMDI, and OBLN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025DRIODarioHealth-$0.07-$0.14-$0.07-$0.14$7.48 million$6.75 million5/8/2025Q1 2025CODXCo-Diagnostics-$0.33-$0.24+$0.09-$0.24$0.38 million$0.05 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBSTGBiostageN/AN/AN/AN/AN/ACODXCo-DiagnosticsN/AN/AN/AN/AN/ADRIODarioHealthN/AN/AN/AN/AN/AOBLNObalon TherapeuticsN/AN/AN/AN/AN/ATMDITitan MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBSTGBiostageN/A2.732.73CODXCo-DiagnosticsN/A4.434.23DRIODarioHealth0.262.011.77OBLNObalon TherapeuticsN/A1.861.86TMDITitan MedicalN/A1.411.41Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBSTGBiostageN/ACODXCo-Diagnostics14.99%DRIODarioHealth33.39%OBLNObalon Therapeutics18.64%TMDITitan Medical3.55%Insider OwnershipCompanyInsider OwnershipBSTGBiostage15.30%CODXCo-Diagnostics8.40%DRIODarioHealth11.20%OBLNObalon Therapeutics8.10%TMDITitan Medical0.02%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBSTGBiostage713.88 million11.76 millionNot OptionableCODXCo-Diagnostics10033.57 million30.75 millionOptionableDRIODarioHealth20044.46 million39.48 millionOptionableOBLNObalon Therapeutics210.02 millionN/ANot OptionableTMDITitan Medical49111.95 million111.93 millionNot OptionableCODX, DRIO, BSTG, TMDI, and OBLN HeadlinesRecent News About These CompaniesConavi Medical Corp. Commences Trading on TSX-V Under Symbol “CNVI”October 18, 2024 | markets.businessinsider.comTitan Submersible HearingsSeptember 25, 2024 | msn.com'All good here' was 1 of the final texts sent from the doomed Titan submersibleSeptember 17, 2024 | news8000.comNMedi Assist, Tata Elxsi, Tata Tech, ABB India Gain While Titan, Minda Corp, Syngene Slump In tradeAugust 27, 2024 | msn.comMasculen Titan ME Review – Is It Really Worth Buying?August 21, 2024 | thedailyworld.comTTitan Enterprises Releases New Display Model of its Popular Pulsite® Link Flow InstrumentAugust 16, 2024 | msn.comTitan Medical Inc.: Titan Medical Reports Operating and Financial Results for the Second Quarter 2024August 16, 2024 | finanznachrichten.deTitan Pharmaceuticals: Q1 Earnings SnapshotMay 15, 2024 | smdailyjournal.comSTitan Medical Inc.: Titan Medical Reports Financial Results for the First Quarter 2024May 13, 2024 | finanznachrichten.deTMD:CA Titan Medical Inc.April 21, 2024 | seekingalpha.comTitan Medical Inc.: Titan Medical Reports Fiscal Year 2023 ResultsApril 1, 2024 | finanznachrichten.deTitan Medical signs deal to merge with Conavi MedicalMarch 21, 2024 | msn.comTitan Medical Inc TMDIFFebruary 27, 2024 | morningstar.comMPerifery appoints Titan Data Solutions as authorised distributorFebruary 13, 2024 | advanced-television.comATitan Medical Inc (TMD)February 13, 2024 | investing.comVantage Titan 3T MRI Scanner from ToshibaJanuary 11, 2024 | news-medical.netNAttack on Titan: Hajime Isayama Will Create New Titan Story in 2024October 3, 2023 | comicbook.comCFive dead on Titan sub were 'true explorers' - OceanGateSeptember 28, 2023 | bbc.comBTMDIF Titan Medical Inc.August 1, 2023 | seekingalpha.comFalse claim Titan passenger was the vice chairman of the World Economic Forum | Fact checkJuly 25, 2023 | usatoday.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCODX, DRIO, BSTG, TMDI, and OBLN Company DescriptionsBiostage OTCMKTS:BSTG$4.45 0.00 (0.00%) As of 07/24/2023Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company's pipeline includes organ-regeneration technology for the repair or replacement of diseased or damaged organs, as well as product candidates to treat cancer, injury, and birth defects of the bronchus. Its lead product candidate is Biostage Esophageal Implant for the treatment of severe esophageal disease. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.Co-Diagnostics NASDAQ:CODX$0.25 0.00 (-0.75%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$0.25 0.00 (-0.40%) As of 07/11/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.DarioHealth NASDAQ:DRIO$0.72 +0.00 (+0.22%) Closing price 07/11/2025 03:59 PM EasternExtended Trading$0.70 -0.01 (-1.95%) As of 07/11/2025 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.Obalon Therapeutics NASDAQ:OBLNObalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallowable capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. Obalon Therapeutics, Inc. was incorporated in 2008 and is headquartered in Carlsbad, California.Titan Medical NASDAQ:TMDITitan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos™ system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation. The company was founded on July 28, 2008 and is headquartered in Toronto, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/07 - 07/11 The Meteoric Rise of Rocket Lab: A Space Stock to Watch Meta and Autonomous Advertising: The Stock's Next Big Tailwind? Super Micro Computer: The Hidden Winner of Soaring Copper Tariffs Nebius Group: Up 385%, Analysts Say It’s Still a Bargain Broadcom Stock: HSBC Sets $400 Target on AI Growth Potential BigBear.ai: Why a 90% Rally Could Be Just the Start Chipotle: Too Spicy for Smart Money to Resist After Stock Split Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
